Annuaire
Myliveroom is a comprehensive directory of virtual events and online communities, designed to help you connect and engage with others from the comfort of your own home. Our user-friendly platform features a wide range of digital gatherings, including webinars, live streams, and web-based events, as well as interactive experiences like video chat, collaborative sessions, and group discussions. With Myliveroom, you can easily find and join online communities based on your interests, network with other professionals, and stay up-to-date on the latest industry trends. Whether you're looking to attend a virtual conference, host a webinar, or simply socialize online, Myliveroom has everything you need to make it happen. Join us today and start exploring all that our directory has to offer!
-
-
Dry Powder Inhaler Market Size & Share Analysis 2034: Key Trends
According to a newly published market research report by 24LifeSciences, global dry powder inhaler device market was valued at USD 756 million in 2024 and is projected to reach USD 1,077 million by 2031, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025-2031.
Dry powder inhalers (DPIs) are handheld medical devices that deliver medication to the lungs in the form of a dry, micronized powder. These devices are primarily used to manage chronic respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), offering a propellant-free alternative to traditional metered-dose inhalers. Their operation relies entirely on the patient's inhalation effort to aerosolize and deliver the medication, making them particularly valuable for patients who struggle with coordination issues associated with other inhaler types. The precision and portability of DPIs have established them as a cornerstone of modern respiratory care, with their application expanding to include systemic drug delivery for conditions like diabetes.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7295/dry-powder-inhaler-device-market
Dry Powder Inhaler Market Size & Share Analysis 2034: Key Trends According to a newly published market research report by 24LifeSciences, global dry powder inhaler device market was valued at USD 756 million in 2024 and is projected to reach USD 1,077 million by 2031, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025-2031. Dry powder inhalers (DPIs) are handheld medical devices that deliver medication to the lungs in the form of a dry, micronized powder. These devices are primarily used to manage chronic respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), offering a propellant-free alternative to traditional metered-dose inhalers. Their operation relies entirely on the patient's inhalation effort to aerosolize and deliver the medication, making them particularly valuable for patients who struggle with coordination issues associated with other inhaler types. The precision and portability of DPIs have established them as a cornerstone of modern respiratory care, with their application expanding to include systemic drug delivery for conditions like diabetes. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7295/dry-powder-inhaler-device-market0 Commentaires 0 Parts 61 Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
